Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6363620 | 0.82 | SLC6A4 (0.52) | SLC6A4 | |
| Hydrochloric Acid SCHEMBL7058624 | 0.81 | CHRNA7 (0.52) | SLC6A4 | |
| SCHEMBL6359173 | 0.77 | SLC6A3 (0.59) | SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL7057462 | 0.76 | SLC6A3 (0.57) | SLC6A4SLC6A3 | |
| SCHEMBL6363932 | 0.75 | CHRNB4 (0.66) | — | |
| SCHEMBL9240718 | 0.75 | SLC6A3 (0.61) | SLC6A3 | |
| SCHEMBL6358060 | 0.75 | CHRNB2 (0.50) | — | |
| Hydrochloric Acid SCHEMBL7055774 | 0.74 | CHRNA7 (0.51) | — | |
| Hydrochloric Acid SCHEMBL7054482 | 0.73 | CHRNB4 (0.64) | — | |
| SCHEMBL6357499 | 0.72 | CHRNB2 (0.66) | SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020038028-A1 | For therapy of neurological and psychological disorders are claimed. | YOHANNES DANIEL (US) | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020038028-A1 | For therapy of neurological and psychological disorders are claimed. | GRIN2C, PNMT, GRIA4 | SLC6A4 54/4885SLC6A3 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.